Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.9
5.2
Journals
Vaccines
Special Issues
Current Status of Monkeypox Vaccines
share announcement

Current Status of Monkeypox Vaccines

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 2428

Special Issue Editor

Prof. Dr. Lawrence Frenkel

E-Mail Website
Guest Editor
St. Peter's University Hospital, New Brunswick, NJ, USA
Interests: COVID; immune

Special Issue Information

Dear Colleagues,

Monkeypox disease has received some increased attention in the United States recently. This special issue will review the epidemiology, clinical manifestations in animals and humans, molecular biology of the virus, and vaccine considerations, including mechanisms of action, adverse effects, as well as the status of new and proposed vaccines. The current animal vectors and clinical trial data in humans will be reviewed.

In this Special Issue, original research articles, reviews, as well as significant case reports are welcome. Research areas may include (but not limited to) the following:

  • Monkeypox virus
  • Monkeypox disease
  • Animal vectors
  • Molecular biology of the virus
  • Vaccine mechanisms of action

We look forward to receiving your contributions.

Prof. Dr. Lawrence D. Frenkel
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • monkeypox
  • vaccine
  • virus

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Other

17 pages, 2315 KiB  
Systematic Review
Attitudes towards Receiving Monkeypox Vaccination: A Systematic Review and Meta-Analysis
by Mostafa Hossam-Eldin Moawad, Amira Mohamed Taha, Dang Nguyen, Mohammed Ali, Yasmine Adel Mohammed, Wesam Abd El-Tawab Moawad, Esraa Hamouda, D. Katterine Bonilla-Aldana and Alfonso J. Rodriguez-Morales
Vaccines 2023, 11(12), 1840; https://doi.org/10.3390/vaccines11121840 - 12 Dec 2023
Cited by 1 | Viewed by 2071
Abstract
Background: The public’s attitude towards Mpox vaccination is a critical factor in the success of immunisation programmes. Understanding the factors contributing to vaccine acceptance or hesitancy is critical for developing effective health communication strategies. This systematic review and meta-analysis aims to bring together [...] Read more.
Background: The public’s attitude towards Mpox vaccination is a critical factor in the success of immunisation programmes. Understanding the factors contributing to vaccine acceptance or hesitancy is critical for developing effective health communication strategies. This systematic review and meta-analysis aims to bring together evidence from observational studies on attitudes towards Mpox vaccination, including willingness and rejection. Methods: From this review’s inception until June 2023, a comprehensive search was conducted across four major electronic databases: PubMed, Web of Science, Scopus, and EBSCO. The inclusion criteria included studies investigating public attitudes towards Mpox vaccination, as defined by acceptance and willingness to be vaccinated versus rejection and unwillingness. Results: Thirty studies met the inclusion criteria among the screened literature. An analysis of 27 studies involving 81,792 participants revealed that 45,926 (56.14%) were willing to receive the Mpox vaccination. In contrast, ten studies involving 7448 participants revealed that 2156 people (28.94%) were unwilling to receive the Mpox vaccination. Females were less willing to receive the vaccine than males, with an odds ratio (OR) of 0.61 (95% CI, 0.43–0.86). Furthermore, homosexuals were found to be more willing than heterosexuals, with an OR of 1.44 (95% CI, 1.14–1.80). Conclusion: Vaccination is emerging as a critical strategy for preventing Mpox infection and fostering herd immunity against potential outbreaks. Improving public awareness and acceptance of vaccination is critical to avoiding a situation similar to the COVID-19 pandemic. Targeted educational and outreach programmes could explain the benefits of vaccination, bridging the information gap and encouraging a proactive public health approach to emerging infectious diseases. Full article
(This article belongs to the Special Issue Current Status of Monkeypox Vaccines)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop